COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 188 filers reported holding COHERUS BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $180,000 | -18.9% | 13,928 | 0.0% | 0.01% | +16.7% |
| Q4 2021 | $222,000 | -0.9% | 13,928 | 0.0% | 0.01% | -14.3% |
| Q3 2021 | $224,000 | +16.1% | 13,928 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $193,000 | -4.9% | 13,928 | 0.0% | 0.01% | -22.2% |
| Q1 2021 | $203,000 | -16.1% | 13,928 | 0.0% | 0.01% | -18.2% |
| Q4 2020 | $242,000 | -5.1% | 13,928 | 0.0% | 0.01% | -31.2% |
| Q3 2020 | $255,000 | +2.4% | 13,928 | 0.0% | 0.02% | +45.5% |
| Q2 2020 | $249,000 | +10.2% | 13,928 | 0.0% | 0.01% | -66.7% |
| Q1 2020 | $226,000 | +9.7% | 13,928 | +21.9% | 0.03% | +83.3% |
| Q4 2019 | $206,000 | -11.2% | 11,428 | 0.0% | 0.02% | +20.0% |
| Q3 2019 | $232,000 | -8.3% | 11,428 | 0.0% | 0.02% | -21.1% |
| Q2 2019 | $253,000 | +62.2% | 11,428 | 0.0% | 0.02% | +90.0% |
| Q1 2019 | $156,000 | +51.5% | 11,428 | 0.0% | 0.01% | +42.9% |
| Q4 2018 | $103,000 | – | 11,428 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |